Manon Callens, Nina Kraskovskaya, Kristina Derevtsova, Wim Annaert, Geert Bultynck, Ilya Bezprozvanny, Tim Vervliet
Journal: Biochimica et biophysica acta. Molecular cell research 2021;1868(6):118997
PMID: 33711363
The family of B-cell lymphoma-2 (Bcl-2) proteins exerts key functions in cellular health. Bcl-2 primarily acts in mitochondria where it controls the initiation of apoptosis. However, during the last decades, it has become clear that this family of proteins is also involved in controlling intracellular Ca signaling, a critical process for the function of most cell types, including neurons. Several anti- and pro-apoptotic Bcl-2 family members are expressed in neurons and impact neuronal function. Importantly, expression levels of neuronal Bcl-2 proteins are affected by age. In this review, we focus on the emerging roles of Bcl-2 proteins in neuronal cells. Specifically, we discuss how their dysregulation contributes to the onset, development, and progression of neurodegeneration in the context of Alzheimer's disease (AD). Aberrant Ca signaling plays an important role in the pathogenesis of AD, and we propose that dysregulation of the Bcl-2-Ca signaling axis may contribute to the progression of AD and that herein, Bcl-2 may constitute a potential therapeutic target for the treatment of AD.
Copyright © 2021 Elsevier B.V. All rights reserved.
Full Text Sources:
Medical:
Other Literature Sources:
Miscellaneous:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.